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Summary
Background Tracking aid ﬂ ows helps to hold donors accountable and to compare the allocation of resources in relation 
to health need. With the use of data reported by donors in 2015, we provided estimates of oﬃ  cial development 
assistance and grants from the Bill & Melinda Gates Foundation (collectively termed ODA+) to reproductive, maternal, 
newborn, and child health for 2013 and complete trends in reproductive, maternal, newborn, and child health support 
for the period 2003–13. 
Methods We coded and analysed ﬁ nancial disbursements to reproductive, maternal, newborn, and child health to all 
recipient countries from all donors reporting to the creditor reporting system database for the year 2013. We also 
revisited disbursement records for the years 2003–08 and coded disbursements relating to reproductive and sexual 
health activities resulting in the Countdown dataset for 2003–13. We matched this dataset to the 2015 creditor 
reporting system dataset and coded any unmatched creditor reporting system records. We analysed trends in ODA+ 
to reproductive, maternal, newborn, and child health for the period 2003–13, trends in donor contributions, 
disbursements to recipient countries, and targeting to need.
Findings Total ODA+ to reproductive, maternal, newborn, and child health reached nearly US$14 billion in 2013, 
of which 48% supported child health ($6·8 billion), 34% supported reproductive and sexual health ($4·7 billion), and 
18% maternal and newborn health ($2·5 billion). ODA+ to reproductive, maternal, newborn, and child health 
increased by 225% in real terms over the period 2003–13. Child health received the most substantial increase in 
funding since 2003 (286%), followed by reproductive and sexual health (194%), and maternal and newborn health 
(164%). In 2013, bilateral donors disbursed 59% of all ODA+ to reproductive, maternal, newborn, and child health, 
followed by global health initiatives (23%), and multilateral agencies (13%). Targeting of ODA+ to reproductive, 
maternal, newborn, and child health to countries with the greatest health need seems to have improved over time.
Interpretation The increase in reproductive, maternal, newborn, and child health funding over the period 2003–13 is 
encouraging. Further increases in funding will be needed to accelerate maternal mortality reduction while keeping a 
high level of investment in sexual and reproductive health and in child health.
Funding Subgrant OPP1058954 from the US Fund for UNICEF under their Countdown to 2015 for Maternal, Newborn 
and Child Survival Grant from the Bill & Melinda Gates Foundation.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
Introduction
Since 1990, maternal and child mortality rates have fallen 
by about half, with the largest reductions occurring since 
2000.1 However, only a third of countries with the greatest 
mortality burden (the 75 Countdown priority countries) 
achieved Millennium Development Goal 4 (MDG 4; 
to reduce the mortality rate in children younger than 
5 years by two-thirds between 1990 and 2015), and only 
6% achieved MDG 5 (to reduce the maternal mortality 
ratio by three-quarters).1 Part of the mortality reductions 
achieved has been attributed to increased coverage of 
life-saving interventions.2 Although vaccination coverage 
and malaria intervention coverage have increased 
substantially, coverage of family planning and safe 
motherhood interventions remain inadequate, and wide 
inequalities in coverage persist.1 Availability of adequate 
ﬁ nancial resources is a factor enabling progress towards 
improved health outcomes, through funding quality 
health services.3–5 In many low-income countries, donor 
funding represents a substantial share of health sector 
ﬁ nancing, amounting to an average of 33% of total health 
expenditure across all low-income countries in 2013.6
As part of the Countdown initiative, we have tracked 
aid ﬂ ows to maternal, newborn, and child health, 
reporting ﬁ ndings every 2 years since 2006. From its 
original focus on tracking aid ﬂ ows to maternal, 
newborn, and child health, our resource tracking exercise 
extended in 2009 to include reproductive and sexual 
health (reproductive, maternal, newborn, and child 
health). Since we began tracking resource ﬂ ows, the 
Institute for Health Metrics and Evaluation (IHME) has 
begun tracking development assistance to the health 
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sector7 and the Partnership for Maternal, Newborn and 
Child Health tracks aid to reproductive, maternal, 
newborn, and child health.8 The resource ﬂ ows project of 
the United Nations Population Fund (UNFPA) and the 
Netherlands Interdisciplinary Demographic Institute, 
tracking international population assistance, has been 
underway since 2002,9 and the Organisation for 
Economic Co-operation and Development recently began 
requesting that donors report on a reproductive, 
maternal, newborn, and child health policy marker as 
part of their oﬃ  cial reporting. Unlike other initiatives, 
we take a detailed approach to resource tracking, coding 
record by record with the use of project descriptions, 
based on a clear conceptual framework and coding 
scheme. This enables us to maintain a highly 
disaggregated classiﬁ cation of projects and to estimate 
the full value of resources beneﬁ ting reproductive, 
maternal, newborn, and child health, including 
a proportion of aid to the health sector, and to the 
humanitarian and other sectors.10–16
This study presents an overview of trends in funding to 
reproductive, maternal, newborn, and child health over 
the period 2003–13. Using data reported by donors in 
2015, we provide estimates for 2013 and updated 
estimates for 2003–12, including complete trends in 
reproductive and sexual health, which had previously 
only been reported from 2009. We present global trends, 
focusing particularly on the 75 Countdown priority 
recipient countries, where over 95% of all maternal and 
child deaths occur, and assess trends in targeting to 
health need.17,18 We reﬂ ect on ﬁ ndings over the period 
2003–13 and at the end of the MDG era, to inform 
accountability exercises related to the Sustainable 
Development Goals.
Methods
Study design
We downloaded oﬃ  cial development assistance (ODA) 
disbursement data for the period 2003–13 from the 
creditor reporting system of the Organisation for 
Economic Co-operation and Development on Jan 7, 2015. 
We obtained data for disbursements made by the Global 
Alliance for Vaccines and Immunization (GAVI) for 
2003–06 directly from GAVI as they were not available 
through the creditor reporting system (Mocova D, GAVI, 
personal communication). We tracked disbursements to 
all recipient countries (147 countries in 2013, plus 
17 regional recipients and unspeciﬁ ed bilateral 
disbursements) from all donors reporting ODA 
disbursements to the creditor reporting system (64 donors 
in 2013) and from the Bill & Melinda Gates Foundation, 
which has reported disbursements to the creditor 
reporting system from 2009 onwards. Although we 
considered private grants rather than ODA, we included 
Bill & Melinda Gates Foundation grants in our analyses 
and we refer to ODA+ when reporting results that include 
these grants. Other oﬃ  cial ﬂ ows were excluded.
We classiﬁ ed aid by donor type, using the Organisation 
for Economic Co-operation and Development deﬁ nitions 
to avoid double counting. We classiﬁ ed as bilateral aid 
Research in context
Evidence before this study
We searched for published literature in Pubmed using the 
terms: global AND (“external funding” OR “resource tracking” 
OR “oﬃ  cial development assistance”) AND (maternal OR 
reproductive OR child OR newborn) for the period 2003–2016.  
We also reviewed Institute of Health Metrics and Evaluation 
(IHME), Partnership for Maternal, Newborn and Child Health 
(PMNCH) and the United Nations Population Fund (UNFPA) 
and the Netherlands Interdisciplinary Demographic Institute 
(NIDI) reports on aid ﬂ ows, downloaded from the IHME, WHO 
and Resource Flows project websites. Several estimates exist of 
oﬃ  cial development assistance plus grants from the Bill & 
Melinda Gates Foundation (ODA+) to reproductive, maternal, 
newborn and child health, including the past publications of 
the Countdown project, two studies examining external 
funding to reproductive health in conﬂ ict-aﬀ ected settings, and 
estimates from the Institute for Health Metrics and Evaluation, 
Partnership for Maternal, Newborn and Child Health and 
UNFPA/NIDI. Past Countdown publications have not previously 
included updated estimates of ODA+ from previous years. 
Added value of this study
This study extends the analysis of ODA+ to reproductive, 
maternal, newborn and child health to include disbursements 
made in 2013, disbursements made in 2003–12 but reported 
later, and corrections to inconsistencies in coding over the 
whole period of the Countdown project. This has resulted in a 
complete dataset of ODA+ disbursements for reproductive, 
maternal, newborn, and child health for the period 2003–13, 
as reported to the Organisation for Economic Co-operation 
and Development creditor reporting system, allowing for the 
ﬁ rst time analyses of trends in complete ODA+ to 
reproductive, maternal, newborn, and child health for the 
full period.
Implications of all the available evidence
We found that ODA+ for reproductive, maternal, newborn, 
and child health increased alongside ODA+ to the health 
sector, and faster than overall increases in ODA+. Increases 
have been greatest for child health, mainly relating to 
immunisation, and reproductive and sexual health, primarily 
relating to HIV; increases for maternal and newborn health 
have been smaller. Targeting to health need seems to have 
improved among recipient countries, particularly from 2009 
to 2013. Diﬀ erent tracking exercises give a wide range of 
estimates.
For more on the creditor 
reporting system see
https://stats.oecd.org/Index.
aspx?DataSetCode=CRS1
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disbursements for which the donor country speciﬁ es the 
recipient country or purpose of aid, and as multilateral aid 
disbursements by multilateral institutions where the 
multilateral institution speciﬁ es the recipient country or 
purpose of aid. We allocated unspeciﬁ ed regional 
disbursements to countries within the given region based 
on their year-speciﬁ c share of direct regional 
disbursements to reproductive, maternal, newborn, and 
child health.13 Where the recipient was reported as 
“bilateral, unspeciﬁ ed”, we included disbursements by 
allocating shares of such disbursements to each country 
receiving direct disbursements, based on their year-
speciﬁ c shares of direct disbursements.
Data coding
Our coding framework classiﬁ es activities into 
27 Countdown codes according to the degree to which 
they respectively beneﬁ t reproductive and sexual health, 
maternal and newborn health, and child health. 
Reproductive and sexual health expenditures are deﬁ ned 
as expenditures on family planning, sexual health, and 
sexually transmitted infections, including HIV.12 
Maternal and newborn health expenditures cover 
activities to restore, improve, and maintain the health of 
women and their newborn babies during pregnancy, 
childbirth, and the ﬁ rst month of life.16 Expenditures for 
child health include activities to restore, improve, and 
maintain the health of children up to 5 years of age.16 
Where age was not speciﬁ ed, “child” was assumed to 
refer to children aged under 5 years. Funding for research 
activities was excluded.
We included funds explicitly earmarked for 
reproductive, maternal, newborn, and child health and 
funds for other activities considered to beneﬁ t 
reproductive, maternal, newborn, and child health, such 
as funds for health system strengthening, general health-
care provision, general budget support, and basket or 
sector funding, as well as some health-condition-speciﬁ c 
funding—eg, funding for malaria and HIV. Funds to 
these broader expenditure categories were allocated to 
reproductive, maternal, newborn, and child health based 
on a set of rules reﬂ ecting the proportion of the 
disbursement considered to beneﬁ t reproductive, 
maternal, newborn, and child health (appendix p 1). For 
condition-speciﬁ c funding, country-speciﬁ c and region-
speciﬁ c rules were based on the proportion of the 
population aged younger than 5 years (malaria, other 
infectious diseases, and conditions aﬀ ecting general 
population health); the proportion of people living with 
HIV who were children aged younger than 5 years and 
women aged 15 years or older (general HIV support); 
and the prevalence of women aged 15–49 among people 
living with any of four sexually transmitted infections 
(Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema 
pallidum, and Trichomonas vaginalis).12 For general budget 
support, the rule was based on the proportion of 
government spending that goes to health and was 
obtained from the National Health Accounts database.6 
The allocation of health systems funds and basket or 
sector funding to reproductive, maternal, newborn, and 
child health was the same for all countries, with estimates 
of spending related to reproductive, maternal, newborn, 
and child health based on the scientiﬁ c literature.16
We reviewed and coded 231 398 disbursement records 
for the year 2013 across all sectors according to 
a previously developed framework.12,16 The only addition 
to the coding method used previously in Countdown 
analyses was that in this iteration, ﬂ ags were added to the 
data to be coded to indicate the presence of key terms 
related to the reproductive, maternal, newborn, and child 
health codes to be assigned. These ﬂ ags were generated 
through searches for terms in the three descriptive 
ﬁ elds—project title, short description, and long 
description—and used to indicate that a record was likely 
to be related to a particular Countdown code. This aimed 
to reduce the cognitive load and increase the speed of 
manual review, and all records were manually coded 
regardless of the presence of ﬂ ags. Where there was any 
ambiguity in coding, we clariﬁ ed and revised the coding 
framework (appendix p 2). To create a fully coded dataset 
for 2003–13, we combined these records with records 
coded in previous rounds of the Countdown project, 
covering 2003–12. As the reproductive and sexual health 
codes were used only from 2009 onwards, we also 
revisited disbursement records for the years 2003–08 
across all sectors, and re-coded those eligible for a 
reproductive and sexual health activity code.
Donors not only add disbursement data to the creditor 
reporting system database but also might change 
previously reported disbursements for earlier years. 
Until now, analyses of disbursement trends did not 
comprehensively update previous analyses to account for 
these changes, nor were thorough consistency checks 
undertaken to compare the assignment of codes over 
time.10–14,16 In each of the six rounds of coding, usually 
one, but up to four researchers, coded the newest 
1 or 2 years of data. To ensure coding consistency over 
time we identiﬁ ed records within the Countdown 
database that were identical on ﬁ ve ﬁ elds (creditor 
reporting system purpose code, project title, short 
description, long description, and donor), but had been 
assigned diﬀ erent Countdown codes. We identiﬁ ed 
82 150 discrepant records in 6616 unique groups of 
records that were identical on the ﬁ ve ﬁ elds. Where one 
record in a group related to a 2013 disbursement, 
all records in that group were assigned the 2013 code; 
where all discrepant records in a group related to 
disbursements between 2003–12, CG or LA reviewed and 
reconciled codes.
To update the Countdown database for the period 
2003–13, we matched the Countdown database to the 
creditor reporting system dataset downloaded in 
January 2015 on the ﬁ ve ﬁ elds. 137 909 records in the 
2015 creditor reporting system had a null or 
See Online for appendix
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zero disbursement value and were coded zero. Where 
records in the 2015 creditor reporting system were 
successfully matched on the ﬁ ve ﬁ elds, they were 
assigned the code from the Countdown database; 
1 428 027 records were coded in this way. We manually 
coded the remaining 556 587 unmatched records. 
We also obtained and coded 1190 records directly from 
GAVI for the period 2003–06 and added them to the 
ﬁ nal dataset. We checked the resulting dataset of 
2 123 713 coded records for 2003–13 for coding 
inconsistencies identiﬁ ed during the dataset preparation 
and corrected codes for 11 136 records. For example, we 
found that vaccination for yellow fever had in some 
years been coded as only beneﬁ ting children (code 415); 
such records were assigned the correct code for 
vaccinations beneﬁ tting the general population 
(436; appendix p 2). The fully coded dataset is available 
online.
Statistical analysis
We analysed trends in ODA+ and ODA+ to the health 
sector over the period 2003–13. ODA+ to the health 
sector was deﬁ ned as funding falling under the following 
purpose codes in the Creditor Reporting System: Health 
(code 120) and Population Policies, Programmes, and 
Reproductive Health (code 130). All creditor reporting 
system purpose codes are listed online. Unlike our 
estimates of ODA+ to reproductive, maternal, newborn,
and child health, the estimate of ODA+ to health does 
not include ODA+ beneﬁ ting health reported to other 
sectors. We analysed trends in donor funding to 
reproductive, maternal, newborn, and child health for 
the period 2003–13. We examined variation in 
reproductive, maternal, newborn, and child health 
funding amounts over time by donor and donor type 
(bilateral, multilateral, global health initiative, and 
private foundation); by funding modality (pooled funding 
versus project funding) and project type; and by recipient 
countries and regions. Data were transferred to Microsoft 
SQL Server Management Studio for data management. 
Data were exported to Microsoft Excel for coding. 
Disbursement data were converted to constant 
2013 US dollars using the donor-speciﬁ c Development 
Assistance Committee deﬂ ators.
We explored whether donors targeted their ODA+ to 
countries with the greatest health needs and whether 
targeting changed over time. For each of the years 
2003–13, we calculated Spearman’s correlation between 
ODA+ to child health per child and mortality in children 
younger than 5 years, ODA+ to maternal and newborn 
health per birth and maternal mortality, ODA+ 
to reproductive and sexual health per woman of 
reproductive age and HIV prevalence, and ODA+ 
to reproductive and sexual health per woman of 
reproductive age and female life expectancy at birth. 
We obtained data for mortality in children younger than 
5 years, maternal mortality, HIV prevalence, and female 
life expectancy from the World Bank’s World 
Development Indicators, and population data from the 
UN World Population Prospects.19 Rather than pick an 
arbitrary lag period, we used disbursements and health-
need indicators from the same year.
Role of the funding source
The funders of the study had no role in the study design, 
data collection, data analysis, data interpretation, 
or writing of the report. The corresponding author had 
full access to all the data in the study and had ﬁ nal 
responsibility to submit for publication.
Results
Total ODA+ to all sectors was estimated at US$161 billion 
in 2013, with ODA+ to the health sector at $24 billion 
(15% of total ODA+), a 10% and 12% increase relative to 
2012, respectively (ﬁ gure 1). Over the period 2003–13, 
total ODA+ to all sectors more than doubled (increase 
of 108%) and ODA+ to the health sector increased more 
than three-fold (219%), with an increase in the share of 
ODA+ allocated to the health sector over time (from 10% 
in 2003 to 15% in 2013; appendix p 4).
Total ODA+ to reproductive, maternal, newborn, and 
child health reached almost US$14·0 billion in 2013, of 
which 48% supported child health ($6·8 billion), 34% 
supported reproductive and sexual health ($4·7 billion), 
and 18% maternal and newborn health (US$2·5 billion; 
appendix p 5). ODA+ to reproductive, maternal, newborn, 
and child health in 2013 was 11% higher than that in 
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Figure 1: Total ODA+, ODA+ to the health sector, and ODA+ to RMNCH from 2003 to 2013
ODA+ to the health sector includes ODA and private grants coded by the donors as supporting the health sector, 
population policies or programmes, or reproductive health as deﬁ ned within the Organisation for
Economic Co-operation and Development’s creditor reporting system database (purpose codes 120 and 130,
respectively). ODA+=oﬃ  cial development assistance plus grants from the Bill & Melinda Gates Foundation. 
RMNCH=reproductive, maternal, newborn, and child health.
For more on creditor reporting 
system purpose codes see 
http://www.oecd.org/dac/stats/
purposecodessectorclassification.
htm
For more on the dataset see 
http://datacompass.lshtm.ac.
uk/232/
For more on Development 
Assistance Committee 
deflators see http://www.oecd.
org/dac/stats/statisticsonresource 
flowstodevelopingcountries.htm
For more on the World Bank’s 
World Development Indicators 
see http://data.worldbank.org/
data-catalog/world-
development-indicators
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2012, with the greatest increase in child health (18%) and 
the lowest for reproductive and sexual health (6%). Over 
the period 2003–13, ODA+ to reproductive, maternal, 
newborn, and child health more than tripled, increasing 
by 225%.
ODA+ to reproductive, maternal, newborn, and child 
health and ODA+ to the health sector increased at 
a similar rate over the period 2003–13. In 2013, 94% of 
the value of our estimate of ODA+ to reproductive, 
maternal, newborn, and child health came from funding 
to the health sector (within the 120 and 130 purpose 
codes); this proportion increased slightly over time, 
ranging from 87–89% in 2003–06 and 90–94% in 2007–13 
(data not shown). Child health received the most 
substantial increase in funding over the period 2003–13 
(286%), followed by reproductive and sexual health 
(194%), and maternal and newborn health (164%).
In 2013, bilateral donors disbursed 59% of all ODA+ to 
reproductive, maternal, newborn, and child health, 
followed by global health initiatives (23%), and 
multilaterals (13%; table 1, appendix p 5). The top four 
donors for reproductive, maternal, newborn, and child 
health over the period 2003–13 were the USA 
(US$32 billion), the Global Fund ($11 billion), the UK 
($7·3 billion), and GAVI ($6·6 billion; appendix p 8). 
These were also the four largest donors in 2013 (ﬁ gure 2, 
table 1). Bilateral funding grew three-fold, and 
multilateral funding increased 1·5-fold over the period 
2003–13. The UK and Canada increased their ODA to 
reproductive, maternal, newborn, and child health four-
fold over this period, the largest relative increase among 
bilateral donors. Most Scandinavian countries (Sweden, 
Denmark, and Finland) decreased their ODA to 
reproductive, maternal, newborn, and child health, as 
did the European economies worst aﬀ ected by the global 
ﬁ nancial crisis, notably Greece and Spain. The only large 
increase among multilateral donors was the seven-fold 
increase from the European Union institutions. Global 
health initiatives increased funding more than nine-fold, 
with a 13-fold increase from the Global Fund and a 
six-fold increase from GAVI (appendix p 6).
ODA+ to the health sector and to reproductive, 
maternal, newborn, and child health has been 
concentrated in the 75 priority countries (ﬁ gure 3, 
appendix p 8). Among the Countdown priority countries, 
ODA+ to reproductive, maternal, newborn, and child 
health increased between 2012 and 2013 (by 12%), 
whereas among the non-priority countries it fell for 
reproductive and sexual health (–6%), maternal and 
newborn health (–6%), and child health (–2%). A greater 
share of ODA+ received by the 75 priority countries was 
disbursed to the health sector compared with non-
priority countries (18% vs 11%), and ODA+ to the health 
sector increased more in priority countries over the 
period 2003–13 than in non-priority countries 
(243% vs 176%). The ratio of reproductive, maternal, 
newborn, and child health ODA+ to health sector ODA+ 
2003 2008 2013 2003–13 average 
annual rate of 
change
Bilateral aid agencies 2855·8 5401·1 8285·0 9%
Australia 111·3 156·0 217·7 5%
Austria 4·6 8·0 4·5 0%
Belgium 46·4 54·2 62·0 2%
Canada 138·2 286·1 560·4 11%
Czech Republic ·· ·· 1·8 ··
Denmark 34·3 52·0 63·0 5%
Estonia ·· ·· 0·4 ··
Finland 15·6 30·4 23·7 3%
France 80·5 64·9 126·1 4%
Germany 141·4 231·1 324·7 7%
Greece 29·3 5·6 0·1 –35%
Iceland ·· ·· 1·8 ··
Ireland 44·5 73·1 50·3 1%
Italy 28·7 61·8 39·4 2%
Japan 117·4 152·2 254·9 6%
South Korea 0·0 29·2 62·4 ··
Kuwait ·· ·· 1·3 ··
Luxembourg 0·0 33·8 24·5 ··
Netherlands 145·7 196·8 195·3 2%
New Zealand 5·7 13·8 13·8 7%
Norway 68·7 146·1 225·4 10%
Poland ·· ·· 0·6 ··
Portugal 3·1 3·1 5·7 5%
Slovakia ·· ·· 0·3 ··
Slovenia ·· ·· 0·4 ··
Spain 56·9 204·7 38·4 –3%
Sweden 70·9 141·4 173·6 7%
Switzerland 29·5 36·4 51·1 4%
United Arab Emirates ·· ·· 68·0 ··
UK 320·1 543·6 1350·5 12%
USA 1362·9 2876·8 4342·8 9%
Multilateral aid agencies 1106·2 1329·5 1822·8 4%
African Development 
Bank
0·0 0·0 0·2 ··
African Development 
Fund
15·5 55·5 23·1 3%
Arab Fund ·· 1·1 1·4 ··
Asian Development 
Bank Special Funds
0·0 0·0 27·0 ··
Arab Bank for Economic 
Development in Africa
·· ·· 0·7 ··
European Union 
institutions
80·7 359·0 532·7 16%
Global Environment 
Facility
0·0 0·3 0·4 ··
International 
Development 
Association
468·6 412·0 565·6 1%
Inter-American 
Development Bank 
Special Fund 
0·0 0·0 35·1 ··
(Table 1 continues on next page)
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was higher in the priority countries than in other 
countries (78% vs 12%). The growth in ODA+ to 
reproductive and sexual health, maternal and newborn 
health, and child health over the period 2003–13 was also 
much greater in priority than non-priority countries: 
205% versus 90% for reproductive and sexual health, 
305% versus 128% for child health, and 190% versus 31% 
for maternal and newborn health.
Similar to previous years, in 2013, of the 75 priority 
countries, Nigeria, Ethiopia, and Kenya received the 
largest total disbursements of ODA+ to reproductive, 
maternal, newborn, and child health, while Equatorial 
Guinea, Turkmenistan, and Gabon received the smallest 
(table 2; appendix p 8). Over the period 2003–13, 
Equatorial Guinea and Brazil experienced the largest 
reductions in ODA+ to reproductive, maternal, newborn, 
and child health (–80% and –74%, respectively), whereas 
Somalia and Nigeria received the greatest relative 
increases, of 878% and 768%, respectively. The total 
disbursements to reproductive, maternal, newborn, and 
child health to several recipient countries varied 
substantially from year to year. For example, 
disbursements to Botswana more than tripled between 
2007 and 2008 from $38 million to $125 million, then fell 
by more than half between 2009 and 2010, from $140 
million to $60 million.
In 2013, ODA+ to child health per child younger than 
5 years and to maternal and newborn health per livebirth 
among the 75 priority countries was highest in 
São Tomé and Príncipe ($130·05 per child and 
$350·58 per livebirth) and lowest in Mexico ($0·07 per child 
and $0·24 per livebirth). The largest change in ODA+ to 
child health per child over the period 2003–13 was seen in 
Lesotho which increased from $6·86 to $103·39 per child 
younger than 5 years (appendix p 11). The largest change 
in ODA+ to maternal and newborn health per livebirth 
was in São Tomé and Príncipe, which increased from 
$112·97 to $350·58 (appendix p 14). In 2013, ODA to 
reproductive and sexual health per woman aged 15–49 was 
highest in Swaziland ($107·14) and lowest in Brazil 
($0·02). The largest change in ODA+ to reproductive and 
sexual health per woman aged 15–49 years over the period 
2003–13 was seen in Swaziland where it increased from 
$20·14 to $107·14 (appendix p 17).
Funding to child health and maternal and newborn 
health has become increasingly targeted to recipient 
countries with higher mortality (table 3). Similarly, 
funding to reproductive and sexual health appears 
increasingly correlated with higher HIV prevalence over 
time, whereas there is little change in the correlation 
between reproductive and sexual health funding and 
female life expectancy. At the end of the period, many 
countries with lower need were still receiving 
substantially more funding per person than other 
countries with higher need (appendix p 21).
As in previous years, almost all (99%) ODA+ to 
reproductive, maternal, newborn, and child health in 
2013 was channelled as projects, rather than general or 
sectoral budget support or through pooled funding 
mechanisms (ﬁ gure 4, appendix p 20). Funds to HIV 
continued to comprise the largest share of project 
funding to reproductive, maternal, newborn, and child 
health (28%), with almost all of these funds being 
general-population disbursements not earmarked to 
reproductive, maternal, newborn, and child health. 
Funding to immunisation constituted the next largest 
area of project funding (18%), followed by reproductive 
health funds (assigned equally between maternal and 
newborn health and reproductive and sexual health; 
15%), and funding for general health-care systems (13%). 
The largest relative increase in disbursements over 
the period 2003–13 was for malaria and HIV 
funding, increasing 14-fold and eight-fold, respectively. 
Disbursements for immunisation activities also 
2003 2008 2013 2003–13 average 
annual rate of 
change
(Continued from previous page)
International Monetary 
Fund (concessional trust 
funds)
37·2 45·6 33·3 –1%
OPEC Fund for 
International 
Development 
·· ·· 11·7 ··
The Joint United 
Nations Programme 
on HIV/AIDS
81·5 61·8 50·1 –4%
UNDP ·· 8·0 7·3 ··
UNFPA 326·8 143·7 150·3 –6%
The UN Refugee Agency ·· ·· 0·0 ··
UNICEF 95·9 201·0 165·2 4%
UN Peacebuilding Fund ·· 0·0 0·0 ··
UNRWA ·· 41·6 42·9 ··
UN World Food 
Programme
·· 0·0 23·1 ··
WHO ·· ·· 152·7 ··
Global health initiatives 344·8 1719·1 3214·2 19%
Global Alliance for 
Vaccines and 
Immunization
212·1 640·7 1371·4 15%
Global Fund to Fight 
AIDS, Tuberculosis and 
Malaria
132·7 1078·4 1842·8 22%
Private donor ·· ·· 667·0 ··
Bill & Melinda Gates 
Foundation
·· ·· 667·0 ··
Total 4306·8 8449·7 13 988·9 9%
Disbursements are in US$ (millions).  Average annual rate of change was calculated as the average annual rate of 
increase necessary starting from the 2003 value to reach the 2013 value; levels of year-on-year change tended to 
ﬂ uctuate. ODA+=oﬃ  cial development assistance plus grants from the Bill & Melinda Gates Foundation. 
OPEC=Organization of the Petroleum Exporting Countries. UNRWA=The United Nations Relief and Works Agency for 
Palestine Refugees in the Near East. 
Table 1: ODA+ to reproductive, maternal, newborn, and child health by donor in 2003, 2008, and 2013 
(2013 constant US$, millions), and average annual rate of increase
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increased by 471% (ﬁ gure 4, appendix p 20). Over the 
period 2003–2013, HIV received the largest amount of 
funds ($2·9 billion), followed by health systems 
($1·6 billion), and reproductive health and immunisation 
(both at $1·3 billion). Although a low share of overall 
funds, ODA+ to both nutrition and family planning has 
continued to grow over the past few years, reaching just 
under $900 million in 2013 in each case.
Discussion
This study extends previous Countdown tracking work 
by examining resource ﬂ ows to reproductive and sexual 
health before 2009, providing an 11 year time series for 
reproductive, maternal, newborn, and child health, and 
incorporating changes to donors’ previously reported 
data. Over the period 2003–13, donors increasingly 
prioritised the health sector within overall ODA+. 
ODA+ to reproductive, maternal, newborn, and child
health increased at a similar rate to ODA+ to the health
sector, with both more than tripling over the 11 year 
period. Over the period of analysis, children aged 
between 1 month and 5 years beneﬁ ted from half of the 
funding to reproductive, maternal, newborn, and child 
health and from the largest increase in donor funding, 
which was driven by substantial increases in funding for 
malaria and immunisation projects. The trends in 
funding are also a function of the evolving landscape of 
donors globally, with the sizable growth in funding from 
global initiatives such as the Global Fund and GAVI in 
ﬁ nancing malaria and HIV projects beneﬁ ting 
reproductive, maternal, newborn, and child health. 
While funding to maternal and newborn health increased 
substantially over the period, this group beneﬁ ted from 
smaller increases than did child health and reproductive 
and sexual health. There were sustained increases in 
health system strengthening, which is essential to 
overcome the bottlenecks in reproductive, maternal, 
newborn, and child health services.20 The MDG ﬁ nal 
report reported greater progress towards MDG 4 on child 
mortality than on MDG 5 on maternal mortality,21 while 
post-neonatal child mortality has declined substantially 
faster than neonatal mortality in the poorest countries.22 
Further funding increases are needed to accelerate 
maternal and neonatal mortality reduction, while 
maintaining a high level of investment in child health.23
Donors have been prioritising their aid ﬂ ows to overall 
health and to reproductive, maternal, newborn, and child 
health towards priority countries, which had a much 
greater growth in related ODA+ over the past 11 years 
than non-priority countries. However, low and decreasing 
budget support and the high level of donor-driven project 
funding limit the potential for the strategic allocation of 
funds to national priorities. There is substantial volatility 
in year-on-year total disbursements to recipient countries, 
which might reﬂ ect unpredictability in funding ﬂ ows, 
or could result from funds for large multiyear projects 
being disbursed in a single year.
The apparent improvement in targeting of ODA+ to 
reproductive, maternal, newborn, and child health to 
countries with the greatest health needs is consistent 
with previous ﬁ ndings on targeting of ODA to HIV.10,13,24 
These trends are encouraging, but should be interpreted 
cautiously. In previous studies, we considered whether 
aid was targeted, reporting improvements in targeting at 
three timepoints. This was done by means of a series of 
Figure 2: Disbursements of ODA+ to reproductive, maternal, newborn, and child health by donor, for top 
ten donors and all others from 2003 to 2013
ODA+=oﬃ  cial development assistance plus grants from the Bill & Melinda Gates Foundation.
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Figure 3: ODA+ to reproductive, maternal, newborn, and child health to priority and non-priority recipients 
from 2003 to 2013
Darker areas represent 75 Countdown priority recipient countries and lighter areas represent all other non-priority 
recipient countries. ODA+=oﬃ  cial development assistance plus grants from the Bill & Melinda Gates Foundation. 
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linear regressions considering the size of the coeﬃ  cient 
together with that of the R² as an indicator of the degree 
of targeting, where larger values were interpreted as 
corresponding to greater targeting.10,11 However, with an 
11 year time series, such analyses would be inappropriate 
as the error terms in a series of univariate regressions 
would be auto-correlated, leading to a biased coeﬃ  cient. 
A systematic assessment of the association between aid 
and recipient-country need and other characteristics, 
with the use of more complex econometric models to 
adjust for auto-correlation, would be an important area 
for future research. Moreover, improved targeting at the 
global level guarantees neither appropriate funding to 
priority needs at the national level, nor appropriate 
subnational distribution of funds.
Our consistency checks, updating of the underlying 
data, and recoding to include estimates for reproductive 
and sexual health before 2009, have led us to revise 
reported estimates for the years 2003–12. For example, 
our estimates for 2011 and 2012 are lower than previously 
reported10 for ODA+ to reproductive and sexual health 
and to child health mainly because of corrections we 
made to coding after the consistency check of historical 
data which showed that in the past some records relating 
to food and humanitarian aid were coded as basic health 
care; these ought to have been excluded according to our 
coding scheme. Changes to donor reporting of project 
descriptions led to some changes. For some donors, our 
estimates exceeded those previously reported, largely 
because donors retrospectively added projects to the 
database. For example, we observed an eight-fold 
increase in the number of projects reported for maternal, 
newborn, and child health for the years 2004 and 2005 by 
Norway in 2015 compared with when these years were 
initially coded, and a 260% increase in the disbursement 
value to maternal, newborn, and child health. For some 
donors, all or nearly all of the disbursements for years 
2003–12 were added retrospectively.
Our estimates of donor assistance to maternal, newborn, 
and child health are $0·4 billion lower than the IHME 
estimates for the year 2013 of $9·7 billion (in 2013 prices). 
However, IHME estimated a much lower increase in 
maternal, newborn, and child health funding over the 
period 2003–13, 93% compared with our estimate of 
242%, which we attribute to important underlying 
diﬀ erences in the concepts measured. The Partnership for 
Maternal, Newborn and Child Health estimated total 
oﬃ  cial development assistance to reproductive, maternal, 
newborn, and child health among the 75 priority countries 
at $12·1 billion (in 2013 prices), $1 billion less than 
estimated here, an increase of 116% between 
2006 and 2013, compared with our estimate of 127% over 
that period. UNFPA and the Netherlands Interdisciplinary 
Demographic Institute estimated international population 
assistance at $11·0 billion in 2012, a 163% increase relative 
to 2003.9 Their deﬁ nition of population activities includes 
the components of reproductive, maternal, and newborn 
2003 2008 2013 2003–13 average 
annual rate of 
change
Afghanistan 50·1 258·5 377·0 17%
Angola 40·8 103·7 98·7 7%
Azerbaijan 3·4 7·9 13·9 11%
Bangladesh 179·8 185·8 412·4 7%
Benin 28·6 58·8 80·2 8%
Bolivia 57·4 52·0 45·3 –2%
Botswana 17·4 124·8 51·6 9%
Brazil 19·9 10·5 5·1 –10%
Burkina Faso 36·6 100·6 136·4 11%
Burundi 21·8 58·5 93·5 12%
Cambodia 69·7 92·0 132·6 5%
Cameroon 26·7 42·7 97·8 11%
Central African Republic 8·7 28·6 37·7 12%
Chad 24·2 40·0 105·6 12%
China 83·9 133·9 41·0 –5%
Comoros 4·6 1·7 9·0 5%
Republic of the Congo 6·5 17·5 18·5 8%
Cote d’Ivoire 41·6 80·3 133·8 9%
Korea 3·9 8·7 24·5 15%
Democratic Republic of the 
Congo
77·3 286·9 549·6 16%
Djibouti 3·0 12·8 9·9 10%
Egypt 47·8 83·2 14·8 –9%
Equatorial Guinea 2·7 11·4 0·5 –12%
Eritrea 33·6 30·7 33·1 0%
Ethiopia 171·2 449·8 872·3 13%
Gabon 2·7 5·0 5·1 5%
Gambia 11·2 11·0 28·2 7%
Ghana 79·8 132·8 257·7 9%
Guatemala 27·1 58·7 41·0 3%
Guinea 21·1 32·6 41·5 5%
Guinea-Bissau 4·7 11·1 27·2 14%
Haiti 45·1 127·2 197·2 12%
India 373·4 509·2 495·4 2%
Indonesia 113·8 136·9 177·3 3%
Iraq 84·0 40·7 28·5 –8%
Kenya 162·7 296·4 755·8 13%
Kyrgyz Republic 28·7 24·1 18·8 –3%
Laos 17·5 27·0 45·8 8%
Lesotho 10·1 25·8 84·2 18%
Liberia 11·3 80·0 94·5 18%
Madagascar 57·3 90·2 143·1 7%
Malawi 105·5 194·9 333·3 9%
Mali 37·7 98·9 199·6 14%
Mauritania 12·3 17·6 17·5 3%
Mexico 10·2 3·7 5·5 –5%
Morocco 29·0 21·3 48·7 4%
Mozambique 136·3 283·1 433·7 9%
Myanmar 24·3 53·4 153·5 15%
Nepal 51·4 76·4 87·1 4%
(Table 2 continues on next page)
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health we analysed and valued at $6·8 billion for 2012, 
with a 166% increase over the same period, and support 
for demographic and programme-related data collection 
and analysis, research, policy development, and training 
and reporting; they exclude child health activities. Data for 
2013 are not yet available. Patel and colleagues25 tracked 
ODA to reproductive health between 2002 and 2011 and 
found a 298% increase in 18 conﬂ ict-aﬀ ected countries, 
which they contrasted with a 323% increase in 36 non-
conﬂ ict-aﬀ ected least developed countries over the same 
period. In December, 2014, the Organisation for Economic 
Co-operation and Development introduced a policy 
marker for reproductive, maternal, newborn, and child 
health, which donors can voluntarily use to mark their 
disbursements as contributing to reproductive, maternal, 
newborn, and child health. As of March 2016, only half of 
donors had reported on this policy marker for 2013, and so 
no time trends were available.
The various approaches to resource tracking diﬀ er 
substantially in their coding methods—Countdown used 
manual review, IHME used automated key-term searches, 
and the Partnership for Maternal, Newborn and Child 
Health used the purpose codes reported by donors to the 
creditor reporting system. Given these diﬀ erences, the 
similarity of the Countdown and IHME estimates for 
maternal, newborn, and child health might be a 
coincidence. We report elsewhere a detailed comparison 
of the methods used by the Countdown, IHME, and the 
Partnership for Maternal, Newborn and Child Health 
initiatives, and the creditor reporting system purpose 
codes and reproductive, maternal, newborn, and child 
health policy marker, commenting on their respective 
strengths and making recommendations for future 
tracking exercises (unpublished).
Our analysis has several limitations. Our method of 
manual coding relies on human interpretation of a coding 
scheme, which makes it diﬃ  cult to replicate because it is 
subjective and highly labour-intensive. It is also dependent 
on the way donors describe projects, and on changes made 
to such descriptions over time. In some cases, projects that 
were previously described as being relevant to reproductive, 
maternal, newborn, and child health by donors, and 
included in our Countdown estimates, were subsequently 
modiﬁ ed within the creditor reporting system database by 
donors, such that they no longer were eligible for 
a Countdown code. Additionally, diﬀ erent people 
undertook the coding over time, which might have 
introduced bias. We hope to have minimised this through 
our standard coding framework and the consistency 
checks done in the data preparation. Our approach to 
allocating disbursements where the recipient was 
“bilateral, unspeciﬁ ed” or was a region might not give 
entirely accurate results for each recipient, but to exclude 
these would have led to a large underestimate of ODA+ to 
reproductive, maternal, newborn, and child health. It is 
very unlikely that such disbursements were distributed by 
recipient such as to change the interpretation. More 
broadly, external funding to reproductive, maternal, 
newborn, and child health is only one source of country-
level funds. Maintenance of gains already made, and 
further improvements in health outcomes, also depend on 
domestic funding and out-of-pocket expenditures, 
including remitted money,26 which are not included in this 
study but are important for funding health systems across 
the world. Country case studies have reported on domestic 
ﬁ nancing levels to reproductive, maternal, newborn, and 
child health in some of the Countdown priority 
countries.23,27,28 In addition to reporting on trends in ODA+, 
it is also important to consider how disbursements reﬂ ect 
aid eﬀ ectiveness principles. Recent initiatives, including 
Every Woman Every Child, refer to reproductive, maternal, 
newborn, child, and adolescent health. While aspects of 
adolescent reproductive and sexual health are included in 
our coding framework, future resource-tracking work 
could include a wider range of adolescent health activities.
2003 2008 2013 2003–13 average 
annual rate of 
change
(Continued from previous page)
Niger 23·2 88·4 107·7 13%
Nigeria 139·6 478·2 1211·5 18%
Pakistan 111·8 215·7 554·8 13%
Papua New Guinea 62·1 84·0 126·8 6%
Peru 24·0 37·2 46·6 5%
Philippines 61·9 57·5 82·0 2%
Rwanda 46·5 169·5 217·0 13%
Sao Tome and Principe 2·3 5·5 8·7 11%
Senegal 67·4 82·8 121·4 5%
Sierra Leone 16·6 46·0 95·0 14%
Solomon Islands 7·8 11·4 16·8 6%
Somalia 9·8 43·4 95·7 19%
South Africa 82·4 291·2 478·0 14%
South Sudan ·· ·· 206·6 ··
Sudan 19·3 168·2 160·9 18%
Swaziland 9·6 16·5 52·1 14%
Tajikistan 7·4 20·5 29·7 11%
Tanzania 129·9 413·4 750·1 14%
Togo 10·8 26·5 46·3 12%
Turkmenistan 2·4 2·2 1·9 –2%
Uganda 153·2 234·5 455·2 9%
Uzbekistan 17·9 20·2 24·6 2%
Vietnam 84·1 99·8 151·9 5%
Yemen 26·7 53·5 202·4 17%
Zambia 118·6 242·0 422·4 10%
Zimbabwe 53·0 87·2 274·8 13%
Total 3805·9 7634·6 13 056·6 10%
Disbursements are in US$ (millions). Average annual rate of change was calculated as the average annual rate of 
increase necessary starting from the 2003 value to reach the 2013 value; in fact, levels of year-on-year change tended 
to ﬂ uctuate. ODA+=oﬃ  cial development assistance plus grants from the Bill & Melinda Gates Foundation.
Table 2: ODA+ to reproductive, maternal, newborn, and child health to 75 Countdown priority recipient 
countries in 2003, 2008, and 2013, and average annual increase
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considerable concern. Systematic comparison of the 
available tracking methods will help to identify an 
optimum approach in terms of timeliness and accuracy 
going forward, and this has been investigated in 
another study (unpublished).
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